SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-013348
Filing Date
2022-08-11
Accepted
2022-08-11 17:22:42
Documents
60
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmbr-20220630x10q.htm   iXBRL 10-Q 1682720
2 EX-31.1 tmbr-20220630xex31d1.htm EX-31.1 17943
3 EX-31.2 tmbr-20220630xex31d2.htm EX-31.2 16227
4 EX-32.1 tmbr-20220630xex32d1.htm EX-32.1 8049
5 EX-32.2 tmbr-20220630xex32d2.htm EX-32.2 9574
  Complete submission text file 0001558370-22-013348.txt   7606520

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmbr-20220630.xsd EX-101.SCH 49769
7 EX-101.CAL tmbr-20220630_cal.xml EX-101.CAL 39238
8 EX-101.DEF tmbr-20220630_def.xml EX-101.DEF 285354
9 EX-101.LAB tmbr-20220630_lab.xml EX-101.LAB 443701
10 EX-101.PRE tmbr-20220630_pre.xml EX-101.PRE 392962
54 EXTRACTED XBRL INSTANCE DOCUMENT tmbr-20220630x10q_htm.xml XML 1477081
Mailing Address 110 ALLEN ROAD, SUITE 401 BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD, SUITE 401 BASKING RIDGE NJ 07920 914-205-3481
Timber Pharmaceuticals, Inc. (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37411 | Film No.: 221156997
SIC: 2834 Pharmaceutical Preparations